Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Tobacco Control|January 26, 2008
Levels and correlates of awareness of tobacco promotional activities among adult smokers in Malaysia and Thailand: findings from the International Tobacco Control Southeast Asia (ITC-SEA) SurveyH-H Yong, R Borland, D Hammond, et al.
Biomedical Physics & Engineering Express|May 22, 2023
Automatic slice thickness measurement on three types of Catphan CT phantomsChoirul Anam, Ariij Naufal, Heri Sutanto, et al.
Carbohydrate Polymers|December 19, 2016
Physicochemical characterization of cellulose nanocrystal and nanoporous self-assembled CNC membrane derived from Ceiba pentandraMohamad Azuwa Mohamed, W N W Salleh, Juhana Jaafar, et al.
Plos One|December 30, 2020
The airways microbiome of individuals with asthma treated with high and low doses of inhaled corticosteroidsMatthew J Martin, Nur Masirah M Zain, Glenn Hearson, et al.
BMC Public Health|February 1, 2015
Cardio-metabolic health risks in indigenous populations of Southeast Asia and the influence of urbanizationMaude E Phipps, Kevin K L Chan, Rakesh Naidu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 13, 2022
Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standardsNur Masirah M Zain, Daniëlle Ter Linden, Andrew K Lilley, et al.
Journal of Medical Microbiology|February 3, 2022
<i>Porphyromonas pasteri</i> and <i>Prevotella nanceiensis</i> in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosisKarmel Webb, Nur Masirah M Zain, Iain Stewart, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 14, 2021
Novel detection of specific bacterial quorum sensing molecules in saliva: Potential non-invasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosisKarmel Webb, Miguel Cámara, Nur Masirah M Zain, et al.
Leukemia|June 1, 2011
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemiaM H Kirschbaum, T Synold, A S Stein, et al.
Cancer|June 22, 2010
A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic scoreAdrienne A Phillips, Iuliana Shapira, Robert D Willim, et al.
Pageof 14